Use nonsteroidal anti-androgen Casodex advanced prostatic carcinoma Pure anti-androgens advantages steroidal anti-androgens cyproterone acetate type treatment patients advanced prostate cancer steroidal side effects marked inhibitory effect libido addition long half-life pure anti-androgen Casodex results maintenance high serum anti-androgen concentrations concern clinical significance small rise serum testosterone concentrations anti-androgen choice treatment androgen-responsive diseases choice extensive clinical evaluations drug monotherapy clinical efficacy tolerability drug important factors anti-androgen choice favorable pharmacokinetics treatment disease high sustained concentrations antagonist present androgenic stimulation Casodex pure anti-androgen long half-life objective subjective responses similar surgical pharmacologic castration profile strong candidate consideration future anti-androgen choice treatment advanced prostate cancer 